Search Browse Earnings

Q/C TECHNOLOGIES, INC. — SlamSEC

Q/C TECHNOLOGIES, INC.

Nasdaq:QCLS

In Vitro & In Vivo Diagnostic Substances·NEW YORK, NY

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$1.7M

-50.4% YoY

FY 2019

Adj. EBITDA

-$17.0M

-1023.6% margin

FY 2024

Net Income

-$4.0M

-240.2% margin

FY 2024

EPS (Diluted)

-$5.33

FY 2024

Stock Price

$4.07

-9.6%

2026-03-09

52W Range

$2.50 – $44.40

P/E Ratio

-0.8x

Market Cap

$17.0M

Cash

$2.7M

FY 2024

Total Debt

$1.5M

FY 2021

Net Cash

$1.2M

FY 2021

Enterprise Value

$15.8M

Debt / EBITDA

0.1x

FY 2019

EV / EBITDA

-0.9x

Employees

—